COMMITTEES 2018-01-25T12:12:26+00:00

Clinical Affairs

Chairperson: A. Vacca

Prof. Dr. Alessandra Vacca
University and A.O.U. of Cagliari
SS 554 bivio per Sestu
Monserrato, Cagliari, Italy
Email: < href=”” taget=”_blanck”>


Project leader: M. Matucci-Cerinic

Project leader: F. van den Hoogen

Project leader: T. Medkour

Project leader: O. Kowal-Bielecka

Project leader: G. Valentini

Basic Science

Chairperson: G. Riemekasten

Prof. Dr. med. G. Riemekasten
Charité – Universitätsmedizin Berlin
Medizinische Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie
Luisenstrasse 13
10117 Berlin

Prof. Dr. med. N. Hunzelmann
Uniklinik Köln
Kerpener Str. 62
50937 Köln

See Introduction

EUSTAR basic science guidelines

EUSTAR Young Investigators Group

The EUSTAR Young Investigators Group is a subgroup of EUSTAR members, first founded in 2007 and lead by young emerging experts in the field of Scleroderma, Dr. Ingo Turner and Dr. Christian Beyer. Now, ten years after its foundation, the EUSTAR Board has chosen Dr. Vincent Sobanski from the University of Lille and Dr. Cosimo Bruni from the University of Florence to be the new co-chairs, aiming at re-building the group and giving it a scientific and prospective role in the field of scleroderma research and communication.

The new EUSTAR Young Investigators Group has so far enrolled 42 members (all under forty) from EUSTAR centres across Europe since Dr. Sobanski and Dr. Bruni took over on May 2017. During their first official meeting at the EULAR Congress 2017 in Madrid, the aims of the Young Investigators Group were outlined and different subgroups were created in order to cover all spectrums of interest in the scleroderma field. First of all, education will be a strategic focus point for this group, aiming at identifying outstanding clinical, epidemiological and basic science news in the field of scleroderma during international congresses and disseminating to the whole scleroderma community, through the use of the Internet and social media. Another important objective of the group, will be to increase the visibility of EUSTAR and help gather more people devoted to scleroderma patients. Moreover, the Young Investigators Group will also have members focussing on previously unexplored areas to create possible future research projects in both basic, transitional and clinical science, and is dedicated to promoting young emerging researchers’ ideas. The Group will be instrumental in helping different EUSTAR centres communicate and share data through the MEDS-online registry, which represents the largest international database of scleroderma patients to date.

Given this new structure and aims of the Group, the EUSTAR Young Investigators Group is getting ready to start work and to endorse education, communication and scientific output of the future systemic sclerosis experts.

The EUSTAR Young Investigators Group is welcoming new members continuously. Please feel free to contact Dr Vincent Sobanski ( or Dr Cosimo Bruni (